Overcoming opioid addiction took a step toward getting a little easier on Wednesday. The United State Food and Drug Administration is approving a new drug, Lucemyra, helping those battling addictions.
The new medicine claims to reduce the symptoms of withdrawal in adults addicted to opiates. Most importantly, however, it does so without using opioids. The drug is the first treatment for withdrawal symptoms to be opioid-free.
Lucemyra could be a significant factor in ending America’s opioid crisis. However, the medication is not a straight up cure for addiction.
Currently, the drug is approved only for short-term use. It is, though, cleared for 14-day doses. The FDA also says Lucemyra may not wholly remove withdrawal symptoms. However, with the current state of opioid abuse in the United States, anything helps.
Lucemyra Could Help Curb Opioid Crisis
In 2016, 63,632 Americans died from drug overdoses. Approximately two-thirds of those deaths involved opioids. Many of the opioid deaths came from prescription drugs.
Facing withdrawal is often the biggest hurdle for those trying to break an addiction. After so long, a user’s body becomes dependant on the drug. If addicts face lessened symptoms, however, quitting can become much more comfortable.
Opioid withdrawal can bring a variety of symptoms. The ailments include physical problems such as vomiting, body pain, excessive sweating, and more. Also, a slew of mental issues can occur as well. Anger issues, anxiety, and insomnia can arise, too.
Typically, people manage opioid addiction by replacing the drug with different opiates. This method allows for a gradual reduction of dependency. It does, however, risk continuing the problem.
Lucemyra, though, offers an opioid-free solution. When used with the proper planning, it should help to curb the epidemic.
The FDA did note the new drug should not be a cure, but more of a stepping stone. Lucemyra can be the first step in a long-term plan, helping get symptoms out of the way early. Once addicts clear the biggest hurdle, they can more easily reach the finish line.